Austin, TX, United States of America

Scott W Rowlinson

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Scott W. Rowlinson: A Pioneer in Arginase Research

Introduction

Scott W. Rowlinson, an accomplished inventor based in Austin, TX, has made significant contributions to the field of biochemistry through his innovative work on arginase. With a total of four patents to his name, his research focuses primarily on methods for the production and application of human recombinant arginase, which holds promise for various therapeutic applications.

Latest Patents

Scott's latest patents showcase his expertise and dedication to advancing medical treatments. One of his notable patents, titled "Methods for production of human recombinant arginase 1 and uses thereof," describes innovative methodologies for producing recombinant Arginase, including PEGylated and cobalt-substituted variants. This patent also outlines pharmaceutical compositions containing such recombinant Arginase and discusses their potential therapeutic uses.

Another significant patent is the "Arginine depletion therapy for treatment of GAMT deficiency." This patent presents methods and compositions for treating GAMT deficiency or guanidino acetate (GAA) toxicity in subjects. It introduces a therapeutic formulation that may include arginase, arginine deiminase, or combinations thereof, ensuring adaptability for intravenous or subcutaneous administration.

Career Highlights

Throughout his career, Scott has worked with esteemed companies such as Aerase, Inc. and Immedica Pharma AB, contributing to their research and development efforts. His extensive knowledge and innovative approach have played a pivotal role in advancing therapeutic strategies in the biotech industry.

Collaborations

Scott has collaborated with talented coworkers such as David Lowe and Anthony G. Quinn, fostering an environment of innovation and idea sharing. These collaborations have helped propel his research to new heights and expand the potential applications of his inventions.

Conclusion

Scott W. Rowlinson's innovative work in the field of arginase research underscores his status as a leading inventor. His contributions through clinical applications and collaborative efforts mark him as a significant figure in advancing medical science. As research progresses, the implications of his patents will likely lead to crucial developments in treating metabolic disorders and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…